02.08.2010
- Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid...
12.07.2010
- Swiss drugmaker Novartis is still seeking to buy out the minority shareholders of eyecare group Alcon with a lowball offer, now worth some $9.7 billion. Here are some key facts...
20.04.2010
- Swiss drugmaker Novartis stuck to its 2010 goals as it posted forecast-beating quarterly figures after governments bought up its flu vaccine during the swine flu pandemic. Earnings...
